Tag Archives: Sunshine Act

"Sunshine" Just the Tip of the Iceberg: Pharma and Full Disclosure

By Jill Wechsler | Published: April 10, 2013
“Sunshine” Just the Tip of the Iceberg: Full Disclosure for Pharma:??There seems no end to demands for data on clinical research, conflicts of interest, company payments, and drug prices, writes Jill Wechsler. Although recent legislation and regulations have greatly expanded the range of information that pharmaceutical companies have to unveil to the public, there’s an escalating [...]
Posted in Guest Blog, Op-Ed, Regulatory, Safety, Strategy, healthcare, pricing | Also tagged , , , | 1 Comment

The Sunshine Act: Cloudier Still?

By Clark Herman | Published: February 7, 2013
With the recent release of the Patient Protection Sunshine Act (PPSA), the Center for Medicare and Medicaid Services (CMS) has established reporting requirements to ensure that drug manufacturers properly disclose payments to physicians in areas of research, continuing medical education, etc. However a key uncertainty is the issue of state pre-emption. While state and local [...]
Posted in Legal, Manufacturing, Medical Education, Meetings, Regulatory, compliance | Also tagged , | 1 Comment

Affordable Care Act: Where's the Sunshine?

By Guest Blogger | Published: September 7, 2012
Where’s the Sunshine? The Senate Special Committee on Aging is holding a Roundtable discussion on Wed. Sept. 12, 2012 in hopes of spurring action to implement the “Sunshine” provisions of the Affordable Care Act (ACA). Policies for collecting and submitting information on pharma payments to doctors were supposed to be issued by last September (2011), so [...]
Posted in Guest Blog, Op-Ed, Regulatory, healthcare | Also tagged , , , | Leave a comment

Compliance: Europe Feels the Sunshine

By Julian Upton | Published: February 15, 2012
As the perceived urgency for transparency and compliance in global pharma grows ever stronger, the ‘Sunshine provisions’ of the US’s Patient Protection and Affordable Care Act (ACA) seem increasingly aptly named. The spotlight that has been exposing and illuminating – and sometimes burning – issues around the financial interests of physicians and academic medical centers [...]
Posted in Europe, compliance | Also tagged , , , , , | Leave a comment

Gift Giving Must Stop Says ProPublica

By Jennifer Ringler | Published: May 9, 2011
According to ProPublica—though transparency has seemingly increased between pharma and physicians since the Christmastime release of its Dollars for Docs report—medical societies and organizations are still having a holiday with industry money. Three days before Christmas last year, independent news organization ProPublica released its own “naughty and nice” list in the form of its Dollars for [...]
Posted in Meetings, Regulatory | Also tagged , , | 1 Comment